SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referências do Artigo

OKOSHI, Katashi et al. Miocardiopatia diabética. Arq Bras Endocrinol Metab [online]. 2007, vol.51, n.2, pp. 160-167. ISSN 0004-2730.  http://dx.doi.org/10.1590/S0004-27302007000200004.

    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetics: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53. [ Links ]

    2. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care 1992;15:1509-16. [ Links ]

    3. Torquato MT, Montenegro RM Jr, Viana LA, Souza RA, Lanna CM, Lucas JC, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30–69 years in Ribeirão Preto (São Paulo), Brazil. São Paulo Med J 2003;121:224-30. [ Links ]

    4. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34. [ Links ]

    5. Giugliano D, Ceriello A, Paoglisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-65. [ Links ]

    6. Gu K, Cowie CC, Harris ML. Diabetes and decline in heart disease mortality in U.S. adults. JAMA 1999;281:1291-7. [ Links ]

    7. Rubler S, Dluglash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595-602. [ Links ]

    8. Codinach-Huix P, Freixa-Pamias R. Diabetic cardiomyopathy: concept, heart function, and pathogenesis. An Med Intern 2002;19:313-20. [ Links ]

    9. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure. Am J Cardiol 1974;34:29-34. [ Links ]

    10. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of the Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996;77:1017-20. [ Links ]

    11. Ryden L, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, et al. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J 2000;21:1967-78. [ Links ]

    12. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-sosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10. [ Links ]

    13. Rossen JD. Abnormal microvascular function in diabetes: relationship to diabetic cardiomyopathy. Coron Artery Dis 1996;7:133-8. [ Links ]

    14. Zoneraich S, Silverman G, Zoneraich O. Primary myocardial disease, diabetes mellitus, and small vessel disease. Am Heart J 1980;100:754-5. [ Links ]

    15. Gutierrez PS, Higuchi ML. Alterações cardíacas e vasculares no diabetes: aspectos anatomopatológicos. Rev Soc Cardiol Estado São Paulo 1998;8:1020-4. [ Links ]

    16. Chaves FR, Jorge PAR. Miocardiopatia diabética. Arq Bras Endocrinol Metab 1998;42:134-9. [ Links ]

    17. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12. [ Links ]

    18. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-9. [ Links ]

    19. Mukamal KJ, Nesto RW, Cohen MC, Muller JE, Maclure M, Sherwood JB. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001;24:1422-7. [ Links ]

    20. Boyer JK, Thanigaraj S, Schechtman KB, Perez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004;93:870-5. [ Links ]

    21. Braga JC, Guimarães Filho FV, Padovani CR, Matsubara BB. Diastolic dysfunction in diabetic normotensive patients, regardless of the presence of microangiopathy. Arq Bras Cardiol 2005;84:461-6. [ Links ]

    22. Gonzalez-Vilchez F, Ayuela J, Ares M, Pi J, Catillo L, Martin-Duran R. Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients. Int J Cardiol 2005;101:53-8. [ Links ]

    23. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006;98:596-605. [ Links ]

    24. Di Muzio BP, Okoshi K, Cicogna AC, Novelli ELB, Dal Pai Silva M, Okoshi MP, et al. Avaliação funcional (in vivo e in vitro) e histológica do ventrículo esquerdo e bioquímica de ratos com diabetes mellitus induzido por estreptozotocina. Rev Soc Cardiol Estado de São Paulo 2006;16:144. [ Links ]

    25. Joffe II, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan JP, et al. Abnormal cardiac function in the streptozotocin-induced, non-insulin-dependent diabetic rat. J Am Coll Cardiol 1999;34:2111-9. [ Links ]

    26. Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 2002;51:1166-71. [ Links ]

    27. Wang P, Lloyd SG, Zeng H, Bonen A, Chatham JC. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 2005;288:H2102-10. [ Links ]

    28. Guimarães JFC, Okoshi K, Cicogna AC, Padovani CR, Cal Pai Silva M, Okoshi MP, et al. Avaliação funcional (in vivo e in vitro) e histológica do ventrículo esquerdo e bioquímica de ratos diabéticos tratados com o flavonóide rutina. Rev Soc Cardiol Estado de São Paulo 2006;16:36. [ Links ]

    29. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci 2004;107:539-57. [ Links ]

    30. Ding A, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006;291:H1489-506. [ Links ]

    31. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001;108:437-46. [ Links ]

    32. Hattori Y, Matsuda N, Kimura J, Ishitani T, Tamada A, Gando S, et al. Diminished function and expression of the cardiac Na+-Ca2 exchanger in diabetic rats: implication in Ca2 overload. J Physiol 2000;527:85-94. [ Links ]

    33. Belke DD, Swanson EA, Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 2004;53:3201-8. [ Links ]

    34. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000;97:1784-9. [ Links ]

    35. Ueno M, Carvalheira JB, Tambascia RC, Bezerra RM, Amaral ME, Carneiro EM, et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia 2005;4:506-18. [ Links ]

    36. Kern W, Peters A, Born J, Fehm HL, Schultes B. Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia. Metabolism 2005;54:391-6. [ Links ]

    37. Wang CC, Goalstone ML, Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 2004;53:2735-40. [ Links ]

    38. Bidasee KR, Nallani K, Yu Y, Cocklin RR, Zhang Y, Wang M, et al. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 2003;52:1825-36. [ Links ]

    39. Bidasee KR, Zhang Y, Shao CH, Wang M, Patel KP, Dincer UD, et al. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 2004;53:463-73. [ Links ]

    40. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, et al. Glycaemic control and heart failure among adult patients with diabetes. Circulation 2001;103:2668-73. [ Links ]

    41. Matsubara BB, Okoshi K, Okoshi MP, Matsubara LS, Pimenta WP, Christovan JC, et al. Disfunção arterial como possível mecanismo de agressão cardíaca em pacientes com diabetes mellitus tipo II. Estudo doppler-ecocardiográfico. Arq Bras Cardiol 1997;69:155-9. [ Links ]

    42. Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999;100:813-9. [ Links ]

    43. Buyukgebiz A, Saylam G, Dundar B, Bober E, Unal N, Akcoral A. Dilated cardiomyopathy as the first early complication in a 14 year-old girl with diabetes mellitus type 1. J Pediatr Endocrinol Metab 2000;13:1143-6. [ Links ]

    44. Schannwell CM, Schneppenheim M, Pering S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002;98:33-9. [ Links ]

    45. Struthers AD, Morris AD. Screening for and treating left ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 2002;359:1430-2. [ Links ]

    46. Von Bibra H, Thrainsdottir IS, Hansen A, Dounis V, Malmberg K, Ryden L. Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2005;2:24-30. [ Links ]

    47. Valle R, Bagolin E, Canali C, Giovinazzo P, Barro S, Aspromonte N, et al. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocardiogr 2006;7:40-4. [ Links ]

    48. Revisão das II Diretrizes da Sociedade Brasileira de Cardiologia para o diagnóstico e tratamento da insuficiência cardíaca. Arq Bras Cardiol 2002;79:1-30. [ Links ]